Target intelligence / Profile preview

Tumor Cell Lysis via Viral Oncolysis

Molecular classification
Virus, Therapeutic strategy
01

Overview

Tumor cell lysis via viral oncolysis refers to the process by which oncolytic viruses (OVs) selectively infect, replicate within, and destroy cancer cells. This mechanism exploits the unique vulnerabilities of tumor cells—such as defective antiviral responses and altered surface receptors—allowing OVs to preferentially target malignant tissue while sparing normal cells. Effectiveness stems from both direct destruction of infected tumor cells and stimulation/modulation of host immune responses against residual disease.

Other names
Oncolytic virotherapyViral oncolysis
02

Mechanism of action

Direct lysis of tumor cells by viral replication and induction of anti-tumor immunity.

03

Biological functions

Tumor cell lysisImmune stimulationAntigen presentationT-cell activationVascular disruption
04

Disease associations

Cancer
05

Safety considerations

Off-target effectsImmune-related adverse eventsViral sheddingDevelopment of anti-viral immunity
06

Interacting drugs

T-VEC

1 more in the full profile.

Beyond the preview

Go deeper on Tumor Cell Lysis via Viral Oncolysis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Cell Lysis via Viral Oncolysis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call